Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management-Reference-Cited by-同舟云学术

Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management

Published:2023-05-04 Issue:5 Volume:16 Page:423-434
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Ruggiero Rosanna¹²,Di Napoli Raffaella¹²,Balzano Nunzia¹²,Ruggiero Donatella¹²,Riccardi Consiglia¹²,Anatriello Antonietta¹²,Cantone Andrea¹²,Sportiello Liberata¹²,Rossi Francesco¹,Capuano Annalisa¹

Affiliation:

1. Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy

2. Department of Experimental Medicine, Section of Pharmacology “L. Donatelli”, University of Campania “Luigi Vanvitelli”, Napoli, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2211262

Reference98 articles.

1. Promising approaches in cancer immunotherapy

2. Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials

3. Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape

4. Immune Checkpoint Inhibitors in Cancer Therapy

5. SnapShot: Cancer immunoediting

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application;Frontiers in Immunology;2024-05-02

2. Sex and gender differences and pharmacovigilance: a knot still to be untied;Frontiers in Pharmacology;2024-04-17

3. Fever of unknown origin associated with immune checkpoint inhibitors;Frontiers in Immunology;2024-03-12

4. Achilles’ Heel of currently approved immune checkpoint inhibitors: immune related adverse events;Frontiers in Immunology;2024-02-12

5. Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review;Frontiers in Immunology;2024-01-12